Field Notes #5: 'Psychedelics Week' in Washington D.C.
Welcome to our fifth Field Note. As a reminder, Field Notes are timely, candid voice notes from our Founder and Editor, Josh Hardman, that give our Pα+ readers a pulse on recent developments in psychedelic drug development, policy, and access.
In this Field Note, Josh shared his notes from a busy week in Washington, D.C., including three meetings:
- FDA’s part 15 psychedelics public hearing
- ARPA-H’s ibogaine initiative (ASCENT-IBO) Proposers Day
- A congressional briefing on psychedelics
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In